6-[2-(4-methylsulfonylpiperazin-1-yl)ethoxy]-2-pyrimidin-5-yl-3-[4-(trifluoromethyl)phenyl]inden-1-one
C27H25F3N4O4S — CID 51002538
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[2-(4-methylsulfonylpiperazin-1-yl)ethoxy]-2-pyrimidin-5-yl-3-[4-(trifluoromethyl)phenyl]inden-1-one
6-[2-(4-methylsulfonylpiperazin-1-yl)ethoxy]-2-pyrimidin-5-yl-3-[4-(trifluoromethyl)phenyl]inden-1-one (PubChem CID 51002538) has the molecular formula C27H25F3N4O4S and a molecular weight of 558.58 g/mol. Its IUPAC name is 6-[2-(4-methylsulfonylpiperazin-1-yl)ethoxy]-2-pyrimidin-5-yl-3-[4-(trifluoromethyl)phenyl]inden-1-one.
Molecular Properties
| Compound Name | 6-[2-(4-methylsulfonylpiperazin-1-yl)ethoxy]-2-pyrimidin-5-yl-3-[4-(trifluoromethyl)phenyl]inden-1-one |
|---|---|
| PubChem CID | 51002538 |
| Molecular Formula | C27H25F3N4O4S |
| Molecular Weight | 558.58 g/mol |
| Exact Mass | 558.15 |
| IUPAC Name | 6-[2-(4-methylsulfonylpiperazin-1-yl)ethoxy]-2-pyrimidin-5-yl-3-[4-(trifluoromethyl)phenyl]inden-1-one |
| SMILES | CS(=O)(=O)N1CCN(CCOc2ccc3c(c2)C(=O)C(c2cncnc2)=C3c2ccc(C(F)(F)F)cc2)CC1 |
| InChI | InChI=1S/C27H25F3N4O4S/c1-39(36,37)34-10-8-33(9-11-34)12-13-38-21-6-7-22-23(14-21)26(35)25(19-15-31-17-32-16-19)24(22)18-2-4-20(5-3-18)27(28,29)30/h2-7,14-17H,8-13H2,1H3 |
| InChIKey | IBAHAGVZXHVHOI-UHFFFAOYSA-N |
| XLogP | 3.61 |
| TPSA | 92.70 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 558.58 |
| LogP ≤ 5 | 3.61 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 51002538 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.